Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Eliem Therapeutics (ELYM)
NASDAQ:ELYM
RESEARCH TOOLSreports
Eliem Therapeutics (ELYM) Stock Price & Analysis
35 Followers
ELYM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.35 - $11.55
Previous Close$7.05
Volume93.68K
Average Volume (3M)951.41K
Market Cap
$470.84M
Enterprise Value$366.06M
Total Cash (Recent Filing)$105.00M
Total Debt (Recent Filing)$225.00K
Price to Earnings (P/E)―
Beta-0.42
Next Earnings
May 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.53
Shares Outstanding29,091,166
10 Day Avg. Volume90,309
30 Day Avg. Volume951,415
Standard Deviation0.33
R-Squared0.00242
Alpha0.00511
Financial Highlights & Ratios
Price to Book (P/B)2.20
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)17.30
P/FCF Ratio17.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-10.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Eliem Therapeutics News
PremiumCompany Announcements
Eliem Therapeutics Expands Portfolio with Strategic Tenet Acquisition
PremiumCompany Announcements
Eliem Therapeutics Announces Leadership Appointments Amidst Acquisition Moves
PremiumCompany Announcements
Eliem Therapeutics Expands with Tenet Medicines Acquisition
Ownership Overview
16.80% Insiders
0.64% Mutual Funds
25.18% Other Institutional Investors
57.38% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ELYM FAQ
What was Eliem Therapeutics’s price range in the past 12 months?
Eliem Therapeutics lowest stock price was $2.35 and its highest was $11.55 in the past 12 months.
What is Eliem Therapeutics’s market cap?
Currently, no data Available
When is Eliem Therapeutics’s upcoming earnings report date?
Eliem Therapeutics’s upcoming earnings report date is May 13, 2024 which is 51 days ago.
How were Eliem Therapeutics’s earnings last quarter?
Eliem Therapeutics released its earnings results on Mar 04, 2024. The company reported -$0.131 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.131.
Is Eliem Therapeutics overvalued?
According to Wall Street analysts Eliem Therapeutics’s price is currently Overvalued.
Does Eliem Therapeutics pay dividends?
Eliem Therapeutics does not currently pay dividends.
What is Eliem Therapeutics’s EPS estimate?
Eliem Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eliem Therapeutics have?
Eliem Therapeutics has 66,785,446 shares outstanding.
What happened to Eliem Therapeutics’s price movement after its last earnings report?
Eliem Therapeutics reported an EPS of -$0.131 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.591%.
Which hedge fund is a major shareholder of Eliem Therapeutics?
Among the largest hedge funds holding Eliem Therapeutics’s share is RA Capital Management. It holds Eliem Therapeutics’s shares valued at 36M.
---
Eliem Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ELYM Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth $50.0M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
151.78%
12-Months-Change
Fundamentals
Return on Equity
-13.01%
Trailing 12-Months
Asset Growth
-10.44%
Trailing 12-Months
Company Description
Eliem Therapeutics
Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems.
---
ELYM Stock 12 Month Forecast
Average Price Target
―Technical Analysis
---